Efficacy of orchiectomy versus high dose polyoestradiol phosphate (160 mg) in relieving infravesical obstruction in patients with prostatic cancer.
Post voiding residual urine volume (78 patients) and maximum urinary flow rate (59 patients) were measured in prostatic cancer patients treated by orchiectomy or oestrogen (polyoestradiol phosphate 160 mg i.m. monthly) to compare the effects of these endocrine treatments on bladder outlet obstruction caused by prostatic carcinoma. The relieving effect of orchiectomy seemed to be more apparent than that of high dose oestrogen during the first six months of therapy.
Aro
J
J
Koskela Hospital, Helsinki, Finland.
Haapiainen
R
R
Rannikko
S
S
Alfthan
O
O
D000368:Aged; D000369:Aged, 80 and over; D004958:Estradiol / Q000031:analogs & derivatives* / Q000627:therapeutic use; D006801:Humans; D008297:Male; D008875:Middle Aged; D015337:Multicenter Studies as Topic; D009919:Orchiectomy; D011471:Prostatic Neoplasms / Q000150:complications / Q000188:drug therapy / Q000601:surgery*; D011897:Random Allocation; D001748:Urinary Bladder Neck Obstruction / Q000209:etiology / Q000503:physiopathology*; D014563:Urodynamics
D004958:Estradiol; C008958:polyestradiol phosphate